nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—migraine—Acetylsalicylic acid—coronary artery disease	0.464	1	CpDpCtD
Zolmitriptan—HTR1B—Penbutolol—coronary artery disease	0.112	0.441	CbGbCtD
Zolmitriptan—HTR1A—Penbutolol—coronary artery disease	0.0702	0.276	CbGbCtD
Zolmitriptan—CYP1A2—Gemfibrozil—coronary artery disease	0.0313	0.123	CbGbCtD
Zolmitriptan—CYP1A2—Clopidogrel—coronary artery disease	0.0271	0.107	CbGbCtD
Zolmitriptan—CYP1A2—Losartan—coronary artery disease	0.0132	0.0521	CbGbCtD
Zolmitriptan—Melatonin—CALR—coronary artery disease	0.00157	0.502	CrCbGaD
Zolmitriptan—Eletriptan—HTR7—coronary artery disease	0.000346	0.11	CrCbGaD
Zolmitriptan—Melatonin—MPO—coronary artery disease	0.000309	0.0985	CrCbGaD
Zolmitriptan—Almotriptan—CYP2C19—coronary artery disease	0.000276	0.0878	CrCbGaD
Zolmitriptan—Melatonin—ESR1—coronary artery disease	0.000232	0.0739	CrCbGaD
Zolmitriptan—Eletriptan—CYP2C19—coronary artery disease	0.000215	0.0684	CrCbGaD
Zolmitriptan—Melatonin—CYP2C19—coronary artery disease	0.000186	0.0593	CrCbGaD
Zolmitriptan—Dizziness—Simvastatin—coronary artery disease	4.64e-05	0.000245	CcSEcCtD
Zolmitriptan—Rash—Ezetimibe—coronary artery disease	4.64e-05	0.000245	CcSEcCtD
Zolmitriptan—Dermatitis—Ezetimibe—coronary artery disease	4.63e-05	0.000245	CcSEcCtD
Zolmitriptan—Confusional state—Ramipril—coronary artery disease	4.63e-05	0.000245	CcSEcCtD
Zolmitriptan—Discomfort—Timolol—coronary artery disease	4.63e-05	0.000244	CcSEcCtD
Zolmitriptan—Asthenia—Niacin—coronary artery disease	4.62e-05	0.000244	CcSEcCtD
Zolmitriptan—Headache—Ezetimibe—coronary artery disease	4.61e-05	0.000243	CcSEcCtD
Zolmitriptan—Malaise—Lisinopril—coronary artery disease	4.6e-05	0.000243	CcSEcCtD
Zolmitriptan—Oedema—Ramipril—coronary artery disease	4.59e-05	0.000243	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Ramipril—coronary artery disease	4.59e-05	0.000243	CcSEcCtD
Zolmitriptan—Vertigo—Lisinopril—coronary artery disease	4.59e-05	0.000242	CcSEcCtD
Zolmitriptan—Dry mouth—Timolol—coronary artery disease	4.58e-05	0.000242	CcSEcCtD
Zolmitriptan—Pain—Losartan—coronary artery disease	4.58e-05	0.000242	CcSEcCtD
Zolmitriptan—Constipation—Losartan—coronary artery disease	4.58e-05	0.000242	CcSEcCtD
Zolmitriptan—Syncope—Lisinopril—coronary artery disease	4.58e-05	0.000242	CcSEcCtD
Zolmitriptan—Vomiting—Eplerenone—coronary artery disease	4.58e-05	0.000242	CcSEcCtD
Zolmitriptan—Feeling abnormal—Furosemide—coronary artery disease	4.58e-05	0.000242	CcSEcCtD
Zolmitriptan—Leukopenia—Lisinopril—coronary artery disease	4.57e-05	0.000241	CcSEcCtD
Zolmitriptan—Nausea—Fenofibrate—coronary artery disease	4.56e-05	0.000241	CcSEcCtD
Zolmitriptan—Pruritus—Niacin—coronary artery disease	4.56e-05	0.000241	CcSEcCtD
Zolmitriptan—Asthenia—Pravastatin—coronary artery disease	4.55e-05	0.00024	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Furosemide—coronary artery disease	4.54e-05	0.00024	CcSEcCtD
Zolmitriptan—Rash—Eplerenone—coronary artery disease	4.54e-05	0.00024	CcSEcCtD
Zolmitriptan—Urticaria—Perindopril—coronary artery disease	4.54e-05	0.00024	CcSEcCtD
Zolmitriptan—Hypersensitivity—Trandolapril—coronary artery disease	4.54e-05	0.00024	CcSEcCtD
Zolmitriptan—Dermatitis—Eplerenone—coronary artery disease	4.53e-05	0.000239	CcSEcCtD
Zolmitriptan—Diarrhoea—Valsartan—coronary artery disease	4.53e-05	0.000239	CcSEcCtD
Zolmitriptan—Confusional state—Timolol—coronary artery disease	4.53e-05	0.000239	CcSEcCtD
Zolmitriptan—Shock—Ramipril—coronary artery disease	4.52e-05	0.000239	CcSEcCtD
Zolmitriptan—Hypersensitivity—Enalapril—coronary artery disease	4.52e-05	0.000239	CcSEcCtD
Zolmitriptan—Abdominal pain—Perindopril—coronary artery disease	4.51e-05	0.000238	CcSEcCtD
Zolmitriptan—Body temperature increased—Perindopril—coronary artery disease	4.51e-05	0.000238	CcSEcCtD
Zolmitriptan—Palpitations—Lisinopril—coronary artery disease	4.51e-05	0.000238	CcSEcCtD
Zolmitriptan—Diarrhoea—Olmesartan—coronary artery disease	4.51e-05	0.000238	CcSEcCtD
Zolmitriptan—Headache—Eplerenone—coronary artery disease	4.51e-05	0.000238	CcSEcCtD
Zolmitriptan—Nervous system disorder—Ramipril—coronary artery disease	4.5e-05	0.000238	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Ramipril—coronary artery disease	4.5e-05	0.000237	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Timolol—coronary artery disease	4.49e-05	0.000237	CcSEcCtD
Zolmitriptan—Oedema—Timolol—coronary artery disease	4.49e-05	0.000237	CcSEcCtD
Zolmitriptan—Pruritus—Pravastatin—coronary artery disease	4.49e-05	0.000237	CcSEcCtD
Zolmitriptan—Loss of consciousness—Lisinopril—coronary artery disease	4.49e-05	0.000237	CcSEcCtD
Zolmitriptan—Nausea—Clopidogrel—coronary artery disease	4.48e-05	0.000237	CcSEcCtD
Zolmitriptan—Tachycardia—Ramipril—coronary artery disease	4.48e-05	0.000237	CcSEcCtD
Zolmitriptan—Skin disorder—Ramipril—coronary artery disease	4.46e-05	0.000236	CcSEcCtD
Zolmitriptan—Infection—Timolol—coronary artery disease	4.46e-05	0.000236	CcSEcCtD
Zolmitriptan—Vomiting—Simvastatin—coronary artery disease	4.46e-05	0.000235	CcSEcCtD
Zolmitriptan—Hypersensitivity—Telmisartan—coronary artery disease	4.46e-05	0.000235	CcSEcCtD
Zolmitriptan—Cough—Lisinopril—coronary artery disease	4.45e-05	0.000235	CcSEcCtD
Zolmitriptan—Nausea—Lovastatin—coronary artery disease	4.45e-05	0.000235	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Ramipril—coronary artery disease	4.44e-05	0.000234	CcSEcCtD
Zolmitriptan—Rash—Simvastatin—coronary artery disease	4.42e-05	0.000234	CcSEcCtD
Zolmitriptan—Dermatitis—Simvastatin—coronary artery disease	4.42e-05	0.000233	CcSEcCtD
Zolmitriptan—Asthenia—Trandolapril—coronary artery disease	4.42e-05	0.000233	CcSEcCtD
Zolmitriptan—Shock—Timolol—coronary artery disease	4.42e-05	0.000233	CcSEcCtD
Zolmitriptan—Feeling abnormal—Losartan—coronary artery disease	4.41e-05	0.000233	CcSEcCtD
Zolmitriptan—Urticaria—Furosemide—coronary artery disease	4.41e-05	0.000233	CcSEcCtD
Zolmitriptan—Diarrhoea—Niacin—coronary artery disease	4.41e-05	0.000233	CcSEcCtD
Zolmitriptan—Nervous system disorder—Timolol—coronary artery disease	4.4e-05	0.000233	CcSEcCtD
Zolmitriptan—Asthenia—Enalapril—coronary artery disease	4.4e-05	0.000232	CcSEcCtD
Zolmitriptan—Headache—Simvastatin—coronary artery disease	4.39e-05	0.000232	CcSEcCtD
Zolmitriptan—Abdominal pain—Furosemide—coronary artery disease	4.39e-05	0.000232	CcSEcCtD
Zolmitriptan—Body temperature increased—Furosemide—coronary artery disease	4.39e-05	0.000232	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Losartan—coronary artery disease	4.38e-05	0.000231	CcSEcCtD
Zolmitriptan—Dizziness—Valsartan—coronary artery disease	4.38e-05	0.000231	CcSEcCtD
Zolmitriptan—Anorexia—Ramipril—coronary artery disease	4.38e-05	0.000231	CcSEcCtD
Zolmitriptan—Nausea—Ezetimibe—coronary artery disease	4.37e-05	0.000231	CcSEcCtD
Zolmitriptan—Skin disorder—Timolol—coronary artery disease	4.36e-05	0.00023	CcSEcCtD
Zolmitriptan—Dizziness—Olmesartan—coronary artery disease	4.36e-05	0.00023	CcSEcCtD
Zolmitriptan—Pruritus—Trandolapril—coronary artery disease	4.36e-05	0.00023	CcSEcCtD
Zolmitriptan—Chest pain—Lisinopril—coronary artery disease	4.35e-05	0.000229	CcSEcCtD
Zolmitriptan—Myalgia—Lisinopril—coronary artery disease	4.35e-05	0.000229	CcSEcCtD
Zolmitriptan—Arthralgia—Lisinopril—coronary artery disease	4.35e-05	0.000229	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Timolol—coronary artery disease	4.34e-05	0.000229	CcSEcCtD
Zolmitriptan—Asthenia—Telmisartan—coronary artery disease	4.34e-05	0.000229	CcSEcCtD
Zolmitriptan—Pruritus—Enalapril—coronary artery disease	4.34e-05	0.000229	CcSEcCtD
Zolmitriptan—Diarrhoea—Pravastatin—coronary artery disease	4.34e-05	0.000229	CcSEcCtD
Zolmitriptan—Anxiety—Lisinopril—coronary artery disease	4.33e-05	0.000229	CcSEcCtD
Zolmitriptan—Discomfort—Lisinopril—coronary artery disease	4.29e-05	0.000227	CcSEcCtD
Zolmitriptan—Anorexia—Timolol—coronary artery disease	4.28e-05	0.000226	CcSEcCtD
Zolmitriptan—Pruritus—Telmisartan—coronary artery disease	4.28e-05	0.000226	CcSEcCtD
Zolmitriptan—Nausea—Eplerenone—coronary artery disease	4.28e-05	0.000226	CcSEcCtD
Zolmitriptan—Dizziness—Niacin—coronary artery disease	4.26e-05	0.000225	CcSEcCtD
Zolmitriptan—Urticaria—Losartan—coronary artery disease	4.26e-05	0.000225	CcSEcCtD
Zolmitriptan—Dry mouth—Lisinopril—coronary artery disease	4.25e-05	0.000224	CcSEcCtD
Zolmitriptan—Abdominal pain—Losartan—coronary artery disease	4.23e-05	0.000224	CcSEcCtD
Zolmitriptan—Body temperature increased—Losartan—coronary artery disease	4.23e-05	0.000224	CcSEcCtD
Zolmitriptan—Asthenia—Captopril—coronary artery disease	4.22e-05	0.000223	CcSEcCtD
Zolmitriptan—Diarrhoea—Trandolapril—coronary artery disease	4.21e-05	0.000222	CcSEcCtD
Zolmitriptan—Vomiting—Valsartan—coronary artery disease	4.21e-05	0.000222	CcSEcCtD
Zolmitriptan—Confusional state—Lisinopril—coronary artery disease	4.2e-05	0.000222	CcSEcCtD
Zolmitriptan—Diarrhoea—Enalapril—coronary artery disease	4.2e-05	0.000222	CcSEcCtD
Zolmitriptan—Dizziness—Pravastatin—coronary artery disease	4.19e-05	0.000221	CcSEcCtD
Zolmitriptan—Vomiting—Olmesartan—coronary artery disease	4.19e-05	0.000221	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.18e-05	0.000221	CcSEcCtD
Zolmitriptan—Rash—Valsartan—coronary artery disease	4.18e-05	0.000221	CcSEcCtD
Zolmitriptan—Dermatitis—Valsartan—coronary artery disease	4.17e-05	0.00022	CcSEcCtD
Zolmitriptan—Nausea—Simvastatin—coronary artery disease	4.17e-05	0.00022	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Lisinopril—coronary artery disease	4.17e-05	0.00022	CcSEcCtD
Zolmitriptan—Oedema—Lisinopril—coronary artery disease	4.17e-05	0.00022	CcSEcCtD
Zolmitriptan—Pruritus—Captopril—coronary artery disease	4.16e-05	0.00022	CcSEcCtD
Zolmitriptan—Rash—Olmesartan—coronary artery disease	4.16e-05	0.000219	CcSEcCtD
Zolmitriptan—Insomnia—Ramipril—coronary artery disease	4.15e-05	0.000219	CcSEcCtD
Zolmitriptan—Dermatitis—Olmesartan—coronary artery disease	4.15e-05	0.000219	CcSEcCtD
Zolmitriptan—Headache—Valsartan—coronary artery disease	4.15e-05	0.000219	CcSEcCtD
Zolmitriptan—Diarrhoea—Telmisartan—coronary artery disease	4.14e-05	0.000219	CcSEcCtD
Zolmitriptan—Infection—Lisinopril—coronary artery disease	4.14e-05	0.000219	CcSEcCtD
Zolmitriptan—Headache—Olmesartan—coronary artery disease	4.13e-05	0.000218	CcSEcCtD
Zolmitriptan—Paraesthesia—Ramipril—coronary artery disease	4.12e-05	0.000218	CcSEcCtD
Zolmitriptan—Shock—Lisinopril—coronary artery disease	4.1e-05	0.000216	CcSEcCtD
Zolmitriptan—Asthenia—Perindopril—coronary artery disease	4.1e-05	0.000216	CcSEcCtD
Zolmitriptan—Dyspnoea—Ramipril—coronary artery disease	4.1e-05	0.000216	CcSEcCtD
Zolmitriptan—Vomiting—Niacin—coronary artery disease	4.09e-05	0.000216	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Timolol—coronary artery disease	4.09e-05	0.000216	CcSEcCtD
Zolmitriptan—Hypersensitivity—Furosemide—coronary artery disease	4.09e-05	0.000216	CcSEcCtD
Zolmitriptan—Somnolence—Ramipril—coronary artery disease	4.08e-05	0.000216	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Lisinopril—coronary artery disease	4.08e-05	0.000215	CcSEcCtD
Zolmitriptan—Dizziness—Trandolapril—coronary artery disease	4.07e-05	0.000215	CcSEcCtD
Zolmitriptan—Tachycardia—Lisinopril—coronary artery disease	4.07e-05	0.000215	CcSEcCtD
Zolmitriptan—Insomnia—Timolol—coronary artery disease	4.06e-05	0.000214	CcSEcCtD
Zolmitriptan—Rash—Niacin—coronary artery disease	4.06e-05	0.000214	CcSEcCtD
Zolmitriptan—Dermatitis—Niacin—coronary artery disease	4.06e-05	0.000214	CcSEcCtD
Zolmitriptan—Dizziness—Enalapril—coronary artery disease	4.06e-05	0.000214	CcSEcCtD
Zolmitriptan—Skin disorder—Lisinopril—coronary artery disease	4.05e-05	0.000214	CcSEcCtD
Zolmitriptan—Dyspepsia—Ramipril—coronary artery disease	4.04e-05	0.000214	CcSEcCtD
Zolmitriptan—Pruritus—Perindopril—coronary artery disease	4.04e-05	0.000213	CcSEcCtD
Zolmitriptan—Headache—Niacin—coronary artery disease	4.03e-05	0.000213	CcSEcCtD
Zolmitriptan—Paraesthesia—Timolol—coronary artery disease	4.03e-05	0.000213	CcSEcCtD
Zolmitriptan—Vomiting—Pravastatin—coronary artery disease	4.03e-05	0.000213	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Lisinopril—coronary artery disease	4.03e-05	0.000213	CcSEcCtD
Zolmitriptan—Diarrhoea—Captopril—coronary artery disease	4.02e-05	0.000213	CcSEcCtD
Zolmitriptan—Dyspnoea—Timolol—coronary artery disease	4e-05	0.000211	CcSEcCtD
Zolmitriptan—Dizziness—Telmisartan—coronary artery disease	4e-05	0.000211	CcSEcCtD
Zolmitriptan—Rash—Pravastatin—coronary artery disease	4e-05	0.000211	CcSEcCtD
Zolmitriptan—Dermatitis—Pravastatin—coronary artery disease	3.99e-05	0.000211	CcSEcCtD
Zolmitriptan—Decreased appetite—Ramipril—coronary artery disease	3.99e-05	0.000211	CcSEcCtD
Zolmitriptan—Somnolence—Timolol—coronary artery disease	3.99e-05	0.000211	CcSEcCtD
Zolmitriptan—Asthenia—Furosemide—coronary artery disease	3.98e-05	0.00021	CcSEcCtD
Zolmitriptan—Headache—Pravastatin—coronary artery disease	3.97e-05	0.00021	CcSEcCtD
Zolmitriptan—Anorexia—Lisinopril—coronary artery disease	3.97e-05	0.00021	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Ramipril—coronary artery disease	3.97e-05	0.000209	CcSEcCtD
Zolmitriptan—Dyspepsia—Timolol—coronary artery disease	3.95e-05	0.000209	CcSEcCtD
Zolmitriptan—Hypersensitivity—Losartan—coronary artery disease	3.95e-05	0.000208	CcSEcCtD
Zolmitriptan—Nausea—Valsartan—coronary artery disease	3.93e-05	0.000208	CcSEcCtD
Zolmitriptan—Pruritus—Furosemide—coronary artery disease	3.93e-05	0.000207	CcSEcCtD
Zolmitriptan—Constipation—Ramipril—coronary artery disease	3.93e-05	0.000207	CcSEcCtD
Zolmitriptan—Nausea—Olmesartan—coronary artery disease	3.92e-05	0.000207	CcSEcCtD
Zolmitriptan—Vomiting—Trandolapril—coronary artery disease	3.92e-05	0.000207	CcSEcCtD
Zolmitriptan—Diarrhoea—Perindopril—coronary artery disease	3.91e-05	0.000206	CcSEcCtD
Zolmitriptan—Decreased appetite—Timolol—coronary artery disease	3.9e-05	0.000206	CcSEcCtD
Zolmitriptan—Vomiting—Enalapril—coronary artery disease	3.9e-05	0.000206	CcSEcCtD
Zolmitriptan—Dizziness—Captopril—coronary artery disease	3.89e-05	0.000205	CcSEcCtD
Zolmitriptan—Rash—Trandolapril—coronary artery disease	3.88e-05	0.000205	CcSEcCtD
Zolmitriptan—Dermatitis—Trandolapril—coronary artery disease	3.88e-05	0.000205	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Timolol—coronary artery disease	3.88e-05	0.000205	CcSEcCtD
Zolmitriptan—Rash—Enalapril—coronary artery disease	3.87e-05	0.000204	CcSEcCtD
Zolmitriptan—Dermatitis—Enalapril—coronary artery disease	3.86e-05	0.000204	CcSEcCtD
Zolmitriptan—Headache—Trandolapril—coronary artery disease	3.86e-05	0.000204	CcSEcCtD
Zolmitriptan—Vomiting—Telmisartan—coronary artery disease	3.85e-05	0.000203	CcSEcCtD
Zolmitriptan—Asthenia—Losartan—coronary artery disease	3.84e-05	0.000203	CcSEcCtD
Zolmitriptan—Headache—Enalapril—coronary artery disease	3.84e-05	0.000203	CcSEcCtD
Zolmitriptan—Pain—Timolol—coronary artery disease	3.84e-05	0.000203	CcSEcCtD
Zolmitriptan—Nausea—Niacin—coronary artery disease	3.83e-05	0.000202	CcSEcCtD
Zolmitriptan—Rash—Telmisartan—coronary artery disease	3.81e-05	0.000201	CcSEcCtD
Zolmitriptan—Dermatitis—Telmisartan—coronary artery disease	3.81e-05	0.000201	CcSEcCtD
Zolmitriptan—Diarrhoea—Furosemide—coronary artery disease	3.8e-05	0.000201	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.8e-05	0.0002	CcSEcCtD
Zolmitriptan—Pruritus—Losartan—coronary artery disease	3.79e-05	0.0002	CcSEcCtD
Zolmitriptan—Headache—Telmisartan—coronary artery disease	3.79e-05	0.0002	CcSEcCtD
Zolmitriptan—Feeling abnormal—Ramipril—coronary artery disease	3.79e-05	0.0002	CcSEcCtD
Zolmitriptan—Dizziness—Perindopril—coronary artery disease	3.78e-05	0.000199	CcSEcCtD
Zolmitriptan—Insomnia—Lisinopril—coronary artery disease	3.77e-05	0.000199	CcSEcCtD
Zolmitriptan—Nausea—Pravastatin—coronary artery disease	3.77e-05	0.000199	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Ramipril—coronary artery disease	3.76e-05	0.000198	CcSEcCtD
Zolmitriptan—Paraesthesia—Lisinopril—coronary artery disease	3.74e-05	0.000198	CcSEcCtD
Zolmitriptan—Vomiting—Captopril—coronary artery disease	3.74e-05	0.000197	CcSEcCtD
Zolmitriptan—Dyspnoea—Lisinopril—coronary artery disease	3.71e-05	0.000196	CcSEcCtD
Zolmitriptan—Rash—Captopril—coronary artery disease	3.71e-05	0.000196	CcSEcCtD
Zolmitriptan—Dermatitis—Captopril—coronary artery disease	3.71e-05	0.000196	CcSEcCtD
Zolmitriptan—Somnolence—Lisinopril—coronary artery disease	3.7e-05	0.000196	CcSEcCtD
Zolmitriptan—Feeling abnormal—Timolol—coronary artery disease	3.7e-05	0.000195	CcSEcCtD
Zolmitriptan—Headache—Captopril—coronary artery disease	3.69e-05	0.000195	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Timolol—coronary artery disease	3.67e-05	0.000194	CcSEcCtD
Zolmitriptan—Dizziness—Furosemide—coronary artery disease	3.67e-05	0.000194	CcSEcCtD
Zolmitriptan—Dyspepsia—Lisinopril—coronary artery disease	3.67e-05	0.000194	CcSEcCtD
Zolmitriptan—Diarrhoea—Losartan—coronary artery disease	3.67e-05	0.000194	CcSEcCtD
Zolmitriptan—Nausea—Trandolapril—coronary artery disease	3.66e-05	0.000193	CcSEcCtD
Zolmitriptan—Urticaria—Ramipril—coronary artery disease	3.65e-05	0.000193	CcSEcCtD
Zolmitriptan—Nausea—Enalapril—coronary artery disease	3.64e-05	0.000192	CcSEcCtD
Zolmitriptan—Vomiting—Perindopril—coronary artery disease	3.63e-05	0.000192	CcSEcCtD
Zolmitriptan—Body temperature increased—Ramipril—coronary artery disease	3.63e-05	0.000192	CcSEcCtD
Zolmitriptan—Abdominal pain—Ramipril—coronary artery disease	3.63e-05	0.000192	CcSEcCtD
Zolmitriptan—Decreased appetite—Lisinopril—coronary artery disease	3.62e-05	0.000191	CcSEcCtD
Zolmitriptan—Rash—Perindopril—coronary artery disease	3.6e-05	0.00019	CcSEcCtD
Zolmitriptan—Dermatitis—Perindopril—coronary artery disease	3.6e-05	0.00019	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.6e-05	0.00019	CcSEcCtD
Zolmitriptan—Nausea—Telmisartan—coronary artery disease	3.59e-05	0.00019	CcSEcCtD
Zolmitriptan—Headache—Perindopril—coronary artery disease	3.58e-05	0.000189	CcSEcCtD
Zolmitriptan—Urticaria—Timolol—coronary artery disease	3.57e-05	0.000188	CcSEcCtD
Zolmitriptan—Pain—Lisinopril—coronary artery disease	3.56e-05	0.000188	CcSEcCtD
Zolmitriptan—Constipation—Lisinopril—coronary artery disease	3.56e-05	0.000188	CcSEcCtD
Zolmitriptan—Abdominal pain—Timolol—coronary artery disease	3.55e-05	0.000187	CcSEcCtD
Zolmitriptan—Body temperature increased—Timolol—coronary artery disease	3.55e-05	0.000187	CcSEcCtD
Zolmitriptan—Dizziness—Losartan—coronary artery disease	3.54e-05	0.000187	CcSEcCtD
Zolmitriptan—Vomiting—Furosemide—coronary artery disease	3.53e-05	0.000186	CcSEcCtD
Zolmitriptan—Rash—Furosemide—coronary artery disease	3.5e-05	0.000185	CcSEcCtD
Zolmitriptan—Dermatitis—Furosemide—coronary artery disease	3.5e-05	0.000185	CcSEcCtD
Zolmitriptan—Nausea—Captopril—coronary artery disease	3.49e-05	0.000185	CcSEcCtD
Zolmitriptan—Headache—Furosemide—coronary artery disease	3.48e-05	0.000184	CcSEcCtD
Zolmitriptan—Feeling abnormal—Lisinopril—coronary artery disease	3.43e-05	0.000181	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Lisinopril—coronary artery disease	3.41e-05	0.00018	CcSEcCtD
Zolmitriptan—Vomiting—Losartan—coronary artery disease	3.41e-05	0.00018	CcSEcCtD
Zolmitriptan—Nausea—Perindopril—coronary artery disease	3.39e-05	0.000179	CcSEcCtD
Zolmitriptan—Hypersensitivity—Ramipril—coronary artery disease	3.38e-05	0.000179	CcSEcCtD
Zolmitriptan—Rash—Losartan—coronary artery disease	3.38e-05	0.000178	CcSEcCtD
Zolmitriptan—Dermatitis—Losartan—coronary artery disease	3.37e-05	0.000178	CcSEcCtD
Zolmitriptan—Headache—Losartan—coronary artery disease	3.36e-05	0.000177	CcSEcCtD
Zolmitriptan—Urticaria—Lisinopril—coronary artery disease	3.31e-05	0.000175	CcSEcCtD
Zolmitriptan—Hypersensitivity—Timolol—coronary artery disease	3.31e-05	0.000175	CcSEcCtD
Zolmitriptan—Nausea—Furosemide—coronary artery disease	3.3e-05	0.000174	CcSEcCtD
Zolmitriptan—Asthenia—Ramipril—coronary artery disease	3.3e-05	0.000174	CcSEcCtD
Zolmitriptan—Abdominal pain—Lisinopril—coronary artery disease	3.29e-05	0.000174	CcSEcCtD
Zolmitriptan—Body temperature increased—Lisinopril—coronary artery disease	3.29e-05	0.000174	CcSEcCtD
Zolmitriptan—Pruritus—Ramipril—coronary artery disease	3.25e-05	0.000172	CcSEcCtD
Zolmitriptan—Asthenia—Timolol—coronary artery disease	3.22e-05	0.00017	CcSEcCtD
Zolmitriptan—Nausea—Losartan—coronary artery disease	3.18e-05	0.000168	CcSEcCtD
Zolmitriptan—Pruritus—Timolol—coronary artery disease	3.18e-05	0.000168	CcSEcCtD
Zolmitriptan—Diarrhoea—Ramipril—coronary artery disease	3.14e-05	0.000166	CcSEcCtD
Zolmitriptan—Diarrhoea—Timolol—coronary artery disease	3.07e-05	0.000162	CcSEcCtD
Zolmitriptan—Hypersensitivity—Lisinopril—coronary artery disease	3.07e-05	0.000162	CcSEcCtD
Zolmitriptan—Dizziness—Ramipril—coronary artery disease	3.04e-05	0.00016	CcSEcCtD
Zolmitriptan—Asthenia—Lisinopril—coronary artery disease	2.99e-05	0.000158	CcSEcCtD
Zolmitriptan—Dizziness—Timolol—coronary artery disease	2.97e-05	0.000157	CcSEcCtD
Zolmitriptan—Pruritus—Lisinopril—coronary artery disease	2.95e-05	0.000156	CcSEcCtD
Zolmitriptan—Vomiting—Ramipril—coronary artery disease	2.92e-05	0.000154	CcSEcCtD
Zolmitriptan—Rash—Ramipril—coronary artery disease	2.9e-05	0.000153	CcSEcCtD
Zolmitriptan—Dermatitis—Ramipril—coronary artery disease	2.89e-05	0.000153	CcSEcCtD
Zolmitriptan—Headache—Ramipril—coronary artery disease	2.88e-05	0.000152	CcSEcCtD
Zolmitriptan—Vomiting—Timolol—coronary artery disease	2.86e-05	0.000151	CcSEcCtD
Zolmitriptan—Diarrhoea—Lisinopril—coronary artery disease	2.85e-05	0.000151	CcSEcCtD
Zolmitriptan—Rash—Timolol—coronary artery disease	2.83e-05	0.00015	CcSEcCtD
Zolmitriptan—Dermatitis—Timolol—coronary artery disease	2.83e-05	0.000149	CcSEcCtD
Zolmitriptan—Headache—Timolol—coronary artery disease	2.81e-05	0.000149	CcSEcCtD
Zolmitriptan—Dizziness—Lisinopril—coronary artery disease	2.75e-05	0.000145	CcSEcCtD
Zolmitriptan—Nausea—Ramipril—coronary artery disease	2.73e-05	0.000144	CcSEcCtD
Zolmitriptan—Nausea—Timolol—coronary artery disease	2.67e-05	0.000141	CcSEcCtD
Zolmitriptan—Vomiting—Lisinopril—coronary artery disease	2.65e-05	0.00014	CcSEcCtD
Zolmitriptan—Rash—Lisinopril—coronary artery disease	2.63e-05	0.000139	CcSEcCtD
Zolmitriptan—Dermatitis—Lisinopril—coronary artery disease	2.62e-05	0.000139	CcSEcCtD
Zolmitriptan—Headache—Lisinopril—coronary artery disease	2.61e-05	0.000138	CcSEcCtD
Zolmitriptan—Nausea—Lisinopril—coronary artery disease	2.47e-05	0.000131	CcSEcCtD
Zolmitriptan—HTR1A—Signaling by GPCR—CREB1—coronary artery disease	6.19e-06	6.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGTR1—coronary artery disease	6.18e-06	6.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRKCD—coronary artery disease	6.14e-06	6.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HTR2A—coronary artery disease	6.14e-06	6.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—C3—coronary artery disease	6.13e-06	6.89e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AGT—coronary artery disease	6.11e-06	6.87e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC22A3—coronary artery disease	6.1e-06	6.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL2—coronary artery disease	6.06e-06	6.8e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6R—coronary artery disease	6.04e-06	6.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL10—coronary artery disease	6.04e-06	6.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLG—coronary artery disease	6.02e-06	6.76e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HTR2A—coronary artery disease	6.01e-06	6.75e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HADH—coronary artery disease	6.01e-06	6.75e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ARNTL—coronary artery disease	6.01e-06	6.75e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—C3—coronary artery disease	6.01e-06	6.74e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOE—coronary artery disease	5.99e-06	6.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—coronary artery disease	5.93e-06	6.66e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOA1—coronary artery disease	5.92e-06	6.65e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	5.92e-06	6.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRB2—coronary artery disease	5.86e-06	6.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIF1A—coronary artery disease	5.85e-06	6.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGT—coronary artery disease	5.83e-06	6.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCE—coronary artery disease	5.79e-06	6.5e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—JAK2—coronary artery disease	5.78e-06	6.49e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	5.78e-06	6.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SOCS1—coronary artery disease	5.77e-06	6.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—S100B—coronary artery disease	5.76e-06	6.46e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—coronary artery disease	5.73e-06	6.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—coronary artery disease	5.73e-06	6.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LEP—coronary artery disease	5.71e-06	6.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOE—coronary artery disease	5.71e-06	6.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGT—coronary artery disease	5.71e-06	6.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SOCS3—coronary artery disease	5.7e-06	6.4e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	5.7e-06	6.4e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA2—coronary artery disease	5.7e-06	6.4e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX2—coronary artery disease	5.7e-06	6.4e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—coronary artery disease	5.68e-06	6.38e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOA1—coronary artery disease	5.64e-06	6.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—coronary artery disease	5.64e-06	6.33e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFBR2—coronary artery disease	5.63e-06	6.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KITLG—coronary artery disease	5.63e-06	6.32e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HK1—coronary artery disease	5.63e-06	6.32e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCG5—coronary artery disease	5.63e-06	6.32e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX4—coronary artery disease	5.63e-06	6.32e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SULT1A1—coronary artery disease	5.63e-06	6.32e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	5.62e-06	6.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—coronary artery disease	5.59e-06	6.28e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOE—coronary artery disease	5.59e-06	6.28e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LEP—coronary artery disease	5.59e-06	6.28e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HADHA—coronary artery disease	5.56e-06	6.25e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK14—coronary artery disease	5.56e-06	6.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCND1—coronary artery disease	5.53e-06	6.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOA1—coronary artery disease	5.53e-06	6.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT5A—coronary artery disease	5.51e-06	6.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP3—coronary artery disease	5.51e-06	6.18e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTA1—coronary artery disease	5.5e-06	6.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—coronary artery disease	5.48e-06	6.15e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ESR1—coronary artery disease	5.45e-06	6.12e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK14—coronary artery disease	5.44e-06	6.11e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPA—coronary artery disease	5.44e-06	6.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—F2—coronary artery disease	5.38e-06	6.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FN1—coronary artery disease	5.38e-06	6.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—coronary artery disease	5.37e-06	6.03e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6ST—coronary artery disease	5.36e-06	6.02e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ESR1—coronary artery disease	5.34e-06	5.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOB—coronary artery disease	5.32e-06	5.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFKBIA—coronary artery disease	5.32e-06	5.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	5.28e-06	5.92e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—F2—coronary artery disease	5.27e-06	5.92e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FN1—coronary artery disease	5.27e-06	5.92e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLCB3—coronary artery disease	5.27e-06	5.91e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6ST—coronary artery disease	5.25e-06	5.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	5.25e-06	5.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EDN1—coronary artery disease	5.24e-06	5.88e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—coronary artery disease	5.22e-06	5.86e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA5—coronary artery disease	5.21e-06	5.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFKBIA—coronary artery disease	5.21e-06	5.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—coronary artery disease	5.2e-06	5.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL5—coronary artery disease	5.2e-06	5.83e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KIT—coronary artery disease	5.15e-06	5.79e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—POMC—coronary artery disease	5.15e-06	5.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF1—coronary artery disease	5.12e-06	5.75e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CSF2—coronary artery disease	5.12e-06	5.75e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—P4HB—coronary artery disease	5.11e-06	5.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LPL—coronary artery disease	5.08e-06	5.7e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	5.06e-06	5.69e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KIT—coronary artery disease	5.05e-06	5.66e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	5.04e-06	5.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	5.04e-06	5.65e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	5.02e-06	5.63e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.96e-06	5.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GSK3B—coronary artery disease	4.94e-06	5.55e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	4.91e-06	5.51e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.91e-06	5.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—POMC—coronary artery disease	4.9e-06	5.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CREB1—coronary artery disease	4.9e-06	5.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GSK3B—coronary artery disease	4.84e-06	5.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—coronary artery disease	4.82e-06	5.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—POMC—coronary artery disease	4.8e-06	5.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CREB1—coronary artery disease	4.8e-06	5.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL2—coronary artery disease	4.8e-06	5.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	4.79e-06	5.38e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6R—coronary artery disease	4.78e-06	5.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	4.77e-06	5.35e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—VCAN—coronary artery disease	4.73e-06	5.31e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1—coronary artery disease	4.72e-06	5.3e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL2—coronary artery disease	4.7e-06	5.28e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK1—coronary artery disease	4.7e-06	5.27e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDOA—coronary artery disease	4.69e-06	5.27e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—coronary artery disease	4.69e-06	5.27e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6R—coronary artery disease	4.68e-06	5.26e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	4.68e-06	5.26e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1—coronary artery disease	4.62e-06	5.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK1—coronary artery disease	4.6e-06	5.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	4.58e-06	5.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—C3—coronary artery disease	4.57e-06	5.14e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—DCN—coronary artery disease	4.56e-06	5.12e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NOS3—coronary artery disease	4.49e-06	5.04e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—coronary artery disease	4.49e-06	5.04e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SERPINE1—coronary artery disease	4.48e-06	5.03e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDH2—coronary artery disease	4.43e-06	4.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—coronary artery disease	4.42e-06	4.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—coronary artery disease	4.39e-06	4.93e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SERPINE1—coronary artery disease	4.39e-06	4.93e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	4.36e-06	4.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGT—coronary artery disease	4.35e-06	4.88e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK1—coronary artery disease	4.34e-06	4.87e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGF2—coronary artery disease	4.34e-06	4.87e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.32e-06	4.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HBA1—coronary artery disease	4.32e-06	4.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LIPC—coronary artery disease	4.32e-06	4.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2C19—coronary artery disease	4.32e-06	4.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	4.32e-06	4.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOC3—coronary artery disease	4.29e-06	4.82e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOS3—coronary artery disease	4.28e-06	4.8e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LDLR—coronary artery disease	4.27e-06	4.79e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.26e-06	4.79e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LEP—coronary artery disease	4.26e-06	4.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOE—coronary artery disease	4.26e-06	4.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGF2—coronary artery disease	4.25e-06	4.77e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC9A1—coronary artery disease	4.22e-06	4.73e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—coronary artery disease	4.22e-06	4.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOA1—coronary artery disease	4.21e-06	4.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOS3—coronary artery disease	4.19e-06	4.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—coronary artery disease	4.17e-06	4.68e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCLC—coronary artery disease	4.17e-06	4.68e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CETP—coronary artery disease	4.17e-06	4.68e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JAK2—coronary artery disease	4.16e-06	4.67e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	4.14e-06	4.65e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SDC1—coronary artery disease	4.12e-06	4.63e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—coronary artery disease	4.11e-06	4.61e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—coronary artery disease	4.07e-06	4.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JAK2—coronary artery disease	4.07e-06	4.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ESR1—coronary artery disease	4.07e-06	4.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FN1—coronary artery disease	4.02e-06	4.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—F2—coronary artery disease	4.02e-06	4.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	4e-06	4.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—coronary artery disease	3.99e-06	4.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	3.97e-06	4.46e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.89e-06	4.37e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.89e-06	4.37e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.89e-06	4.36e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KIT—coronary artery disease	3.84e-06	4.32e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CTGF—coronary artery disease	3.8e-06	4.27e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—coronary artery disease	3.79e-06	4.26e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.77e-06	4.23e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GOT2—coronary artery disease	3.77e-06	4.23e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—coronary artery disease	3.76e-06	4.23e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—coronary artery disease	3.72e-06	4.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	3.69e-06	4.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—coronary artery disease	3.67e-06	4.12e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—POMC—coronary artery disease	3.66e-06	4.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CREB1—coronary artery disease	3.66e-06	4.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—coronary artery disease	3.63e-06	4.08e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—coronary artery disease	3.61e-06	4.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—coronary artery disease	3.59e-06	4.03e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL2—coronary artery disease	3.58e-06	4.02e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6R—coronary artery disease	3.57e-06	4.01e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—coronary artery disease	3.56e-06	3.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—coronary artery disease	3.53e-06	3.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—coronary artery disease	3.53e-06	3.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1—coronary artery disease	3.52e-06	3.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	3.5e-06	3.93e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.47e-06	3.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—coronary artery disease	3.46e-06	3.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—coronary artery disease	3.43e-06	3.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.4e-06	3.82e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—coronary artery disease	3.36e-06	3.77e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.36e-06	3.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.35e-06	3.76e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	3.34e-06	3.75e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—coronary artery disease	3.33e-06	3.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—coronary artery disease	3.33e-06	3.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	3.26e-06	3.66e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GGT1—coronary artery disease	3.25e-06	3.65e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GOT1—coronary artery disease	3.25e-06	3.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF2—coronary artery disease	3.24e-06	3.63e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOS3—coronary artery disease	3.19e-06	3.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JAK2—coronary artery disease	3.1e-06	3.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	3.08e-06	3.46e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—coronary artery disease	3.07e-06	3.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.04e-06	3.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	3.02e-06	3.39e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.92e-06	3.28e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.9e-06	3.25e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.88e-06	3.24e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAT—coronary artery disease	2.84e-06	3.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	2.83e-06	3.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	2.83e-06	3.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	2.77e-06	3.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	2.77e-06	3.11e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOB—coronary artery disease	2.76e-06	3.1e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	2.73e-06	3.07e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	2.72e-06	3.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—coronary artery disease	2.71e-06	3.04e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—coronary artery disease	2.69e-06	3.02e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.69e-06	3.02e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—coronary artery disease	2.64e-06	2.96e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPL—coronary artery disease	2.64e-06	2.96e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX1—coronary artery disease	2.57e-06	2.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—coronary artery disease	2.56e-06	2.87e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—coronary artery disease	2.53e-06	2.84e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CD36—coronary artery disease	2.5e-06	2.81e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	2.48e-06	2.79e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.47e-06	2.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	2.41e-06	2.7e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.37e-06	2.67e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	2.36e-06	2.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	2.3e-06	2.58e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AGT—coronary artery disease	2.26e-06	2.53e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOE—coronary artery disease	2.21e-06	2.48e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA1—coronary artery disease	2.18e-06	2.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—coronary artery disease	2.13e-06	2.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	2.11e-06	2.37e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.09e-06	2.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—coronary artery disease	2.09e-06	2.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	2.07e-06	2.32e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—coronary artery disease	2.06e-06	2.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—coronary artery disease	1.97e-06	2.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—coronary artery disease	1.93e-06	2.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—coronary artery disease	1.92e-06	2.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—POMC—coronary artery disease	1.9e-06	2.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	1.8e-06	2.02e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—coronary artery disease	1.73e-06	1.94e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NOS3—coronary artery disease	1.66e-06	1.86e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—coronary artery disease	1.59e-06	1.78e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.51e-06	1.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.47e-06	1.65e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—coronary artery disease	9.32e-07	1.05e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—coronary artery disease	7.61e-07	8.54e-06	CbGpPWpGaD
